Mbwasi Romuald, Omolo Calvin Andeve, Ombaka Eva, Kingo Rajabu Mohamedi, Mungai Samuel, Wiedenmayer Karin
St John's University of Tanzania, Dodoma, Tanzania.
School of Pharmacy and Health Sciences, United States International University, Nairobi, Kenya
BMJ Open. 2025 May 21;15(5):e096682. doi: 10.1136/bmjopen-2024-096682.
Antimicrobial resistance (AMR) is a major threat in sub-Saharan Africa (SSA), but assessments of antimicrobial consumption (AMC) are limited. This study aimed to investigate regional AMC and resistance patterns in a representative area of Tanzania and to introduce a method for determining AMC in low-resource settings.
We conducted a retrospective study using prescription data collected over 5 years (2013-2017) from multiple hospitals and selected primary health facilities in the Dodoma Region of Tanzania. The study employed the WHO's Anatomical Therapeutic Chemical (ATC) classification and Daily Defined Dose (DDD) methodology to quantify antimicrobial use. Outpatient prescription records that met our inclusion criteria were analysed, while incomplete records were excluded. Sensitivity testing for frequently prescribed antimicrobials was performed against representative gram-negative and gram-positive bacteria, with resistance expressed as minimum inhibitory concentrations and resistance percentages.
This study was conducted across several high-volume healthcare facilities in the Dodoma Region, encompassing both hospital and primary care settings. The dataset comprises outpatient prescription records from these facilities, representing a significant proportion of the regional healthcare usage. The selected facilities were chosen based on their substantial catchment populations to maximise data volume and relevance.
The primary outcome measure was the DDD per 1000 inhabitants per day (DID) for various antimicrobial classes. Secondary outcomes included the prevalence of specific drugs, such as amoxicillin and erythromycin, and their corresponding resistance profiles. Resistance data were quantitatively analysed, with particular attention given to penicillinase-sensitive penicillins and their resistance rates among gram-negative and Gram-positive bacteria.
Analysis revealed that single penicillins, particularly amoxicillin, dominated prescriptions, accounting for 25% to 60% of hospitals and 13% to 29% of primary health centres. Erythromycin was prescribed in 9.4% to 25.1% of cases across facilities. The overall AMC in the region ranged from 36.7 to 50.2 DID during the study period, with consumption patterns showing an initial increase of 4.3% from 2013 to 2014, a subsequent 29.0% decrease from 2014 to 2015, followed by a 34.1% increase from 2015 to 2016 and a further 37.9% increase from 2016 to 2017. Resistance testing demonstrated that penicillinase-sensitive penicillins exhibited an average resistance rate of 87.3%, with gram-negative and gram-positive bacteria showing resistance levels of 90.1% (±8%) and 83.6% (±8%), respectively, indicating a statistically significant association (p<0.05) between high consumption and elevated resistance.
Our findings reveal that AMC in the Dodoma Region is high and is linked to significant resistance against commonly used agents. This study presents a robust method for monitoring AMC and resistance in a resource-efficient manner, offering potential applicability in similar settings across SSA. The data, though representing only a fraction of total antimicrobial use, underscore the urgent need for targeted antimicrobial stewardship interventions, particularly at the primary healthcare level. Future research should further investigate demographic influences and evaluate intervention strategies to mitigate AMR effectively.
抗菌药物耐药性(AMR)是撒哈拉以南非洲(SSA)面临的重大威胁,但对抗菌药物消费(AMC)的评估有限。本研究旨在调查坦桑尼亚一个代表性地区的区域AMC和耐药模式,并介绍一种在资源匮乏环境中确定AMC的方法。
我们进行了一项回顾性研究,使用从坦桑尼亚多多马地区的多家医院和选定的初级卫生设施收集的5年(2013 - 2017年)处方数据。该研究采用世界卫生组织的解剖治疗化学(ATC)分类和每日限定剂量(DDD)方法来量化抗菌药物的使用。分析符合纳入标准的门诊处方记录,排除不完整记录。对常用抗菌药物针对代表性革兰氏阴性菌和革兰氏阳性菌进行敏感性测试,耐药性以最低抑菌浓度和耐药百分比表示。
本研究在多多马地区的多个高流量医疗机构进行,涵盖医院和初级保健机构。数据集包括这些机构的门诊处方记录,代表了该地区医疗保健使用的很大一部分。所选机构是根据其大量的服务人口来选择的,以最大限度地提高数据量和相关性。
主要结果指标是各类抗菌药物每1000居民每天的DDD(DID)。次要结果包括特定药物(如阿莫西林和红霉素)的流行率及其相应的耐药谱。对耐药数据进行定量分析,特别关注对青霉素酶敏感的青霉素及其在革兰氏阴性菌和革兰氏阳性菌中的耐药率。
分析显示,单一青霉素类药物,尤其是阿莫西林,在处方中占主导地位,在医院中占25%至60%,在初级卫生中心占13%至29%。各机构中9.4%至25.1%的病例开具了红霉素。在研究期间,该地区的总体AMC范围为36.7至50.2 DID,消费模式显示从20